Attached files
| file | filename |
|---|---|
| 8-K/A - FORM 8-K/A - Bausch Health Companies Inc. | d614346d8ka.htm |
| EX-23.2 - EX-23.2 - Bausch Health Companies Inc. | d614346dex232.htm |
| EX-99.3 - EX-99.3 - Bausch Health Companies Inc. | d614346dex993.htm |
| EX-99.4 - EX-99.4 - Bausch Health Companies Inc. | d614346dex994.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No.’s 333-92229, 333-138697, 333-168629, 333-168254, 333-176205) of Valeant Pharmaceuticals International, Inc. of our report dated March 22, 2013, except for the effects of finalization of purchase accounting described in Note 2 — Acquisitions and Licensing Agreements—Acquisition of ISTA Pharmaceuticals, Inc., as to which the date is June 7, 2013 relating to the financial statements of Bausch & Lomb Holdings Incorporated, which are incorporated by reference in the Current Report on Form 8-K/A of Valeant Pharmaceuticals International, Inc. dated October 18, 2013.
PricewaterhouseCoopers LLP
Rochester, NY
October 18, 2013